Research Year in Review

Discussion Topics:

• Summarize key regulatory and policy updates from agencies that oversee clinical research, including FDA, NIH, OHRP, OIG, etc.
• Identify and interpret recent enforcement actions and legal developments that impact research compliance and institutional risk.
• Implement current best practices and compliance strategies to reduce regulatory and enforcement risks in clinical research programs.